A prospective study published in the World Journal of Surgery on Friday suggests that persistent hyperphosphataemia may serve as a surrogate biochemical marker for permanent hypoparathyroidism following total thyroidectomy in low-resource settings.
Phosphate levels could replace a costly hormone test. Researchers Poongkodi Karunakaran, Rangarajan Rajamanickam, and Rajeev Parameswaran evaluated serum phosphate as a potential replacement for the standard biomarker, intact parathyroid hormone (iPTH), in a cohort of 328 patients.
The study defined permanent hypoparathyroidism as iPTH levels remaining below 10 pg/mL persisting beyond 6 months post-TT. Of the patients analyzed, 18 (5.5%) developed permanent hypoparathyroidism. Another 195 (59.5%) experienced transient postoperative hypoparathyroidism.
Multivariable analysis determined that POD2 iPTH, parathyroid autotransplantation, and six-month phosphate levels were all independent predictors of the condition. Both POD2 iPTH levels below 6 pg/mL and six-month phosphate levels above 4.9 mg/dL showed good discriminatory performance in identifying risk. The findings were published in the World Journal of Surgery on November 13, 2026. Persistent hyperphosphataemia may therefore serve as a surrogate biochemical marker during long-term surveillance.
A retrospective cohort study found that patients undergoing thyroidectomy after Roux-en-Y gastric bypass (RYGB) were at increased risk for transient hypocalcemia. The study compared 22 patients with a history of RYGB who underwent thyroidectomy with 551 controls.
A separate meta-analysis, titled “A meta-analysis of risk factors for perioperative transient hypoparathyroidism after thyroidectomy,” published in the Asian Journal of Surgery, provided context on the risks associated with the procedure. People who underwent total thyroidectomy were 65% more likely to experience hypoparathyroidism than those who underwent partial thyroidectomy.
The World Journal of Surgery, which published the new findings on November 13, 2026, was established in 1977 and is the official journal of the International Society of Surgery, published by Springer Science+Business Media. Since July 2004 it has been led by editor-in-chief John G. Hunter of Oregon Health & Science University, and it carries a 2014 impact factor of 2.642.
The meta-analysis also said that people without thyroid cancer were 35% less likely to develop hypoparathyroidism after surgery than those who had cancer. People with higher PTH levels were 17% less likely to develop hypoparathyroidism than those with low levels of this hormone.